thyroxine has been researched along with Pancreatic Neoplasms in 10 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "5% patients had a history of hypothyroidism and all received a replacement hormone therapy with levothyroxine, in particular 20% in metastatic group and 11% in radically resected PDAC patients' group." | 4.12 | Should patients on levothyroxine therapy be screened for pancreatic cancer? ( Balsano, R; Coriano', M; Dalla Valle, R; De Lorenzo, S; Del Rio, P; Garajova, I; Gelsomino, F; Leonardi, F; Ravaioli, M; Tovoli, F, 2022) |
| "Human pancreatic cancer cell (PANC-1 and MPanc96) xenografts were established in nude mice, and the effects of tetrac versus Tetrac NP on tumor growth and tumor angiogenesis were determined." | 1.39 | Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles. ( Bharali, DJ; Davis, FB; Davis, PJ; Lin, HY; Meng, R; Mousa, SA; Stain, SC; Sudha, T; Tang, HY; Yalcin, M, 2013) |
| "Congenital hypothyroidism was diagnosed in related Abyssinian cats." | 1.28 | Preliminary studies on congenital hypothyroidism in a family of Abyssinian cats. ( Gruffydd-Jones, TJ; Jones, BR; Lucke, VM; Sparkes, AH, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garajova, I | 1 |
| Balsano, R | 1 |
| Coriano', M | 1 |
| Gelsomino, F | 1 |
| Tovoli, F | 1 |
| De Lorenzo, S | 1 |
| Del Rio, P | 1 |
| Dalla Valle, R | 1 |
| Ravaioli, M | 1 |
| Leonardi, F | 1 |
| Strzałka, A | 1 |
| Hogendorf, P | 1 |
| Skulimowski, A | 1 |
| Spychalski, M | 1 |
| Strzelczyk, J | 1 |
| Durczynski, A | 1 |
| Drzayich Antol, D | 1 |
| Waldman Casebeer, A | 1 |
| Khoury, R | 1 |
| Michael, T | 1 |
| Renda, A | 1 |
| Hopson, S | 1 |
| Parikh, A | 1 |
| Stein, A | 1 |
| Costantino, M | 1 |
| Stemkowski, S | 1 |
| Bunce, M | 1 |
| Nevo, N | 1 |
| Abu-Abeid, S | 1 |
| Hazzan, D | 1 |
| Lahat, G | 1 |
| Nachmani, I | 1 |
| Eldar, SM | 1 |
| Zhang, L | 1 |
| Xia, X | 1 |
| Zhong, Y | 1 |
| Xie, D | 1 |
| Liu, S | 1 |
| Wang, X | 1 |
| Tu, J | 1 |
| Faconti, L | 1 |
| Mills, CE | 1 |
| Govoni, V | 1 |
| Gu, H | 1 |
| Morant, S | 1 |
| Jiang, B | 1 |
| Cruickshank, JK | 1 |
| Webb, AJ | 1 |
| Lin, J | 1 |
| Wu, YJ | 1 |
| Liang, X | 1 |
| Ji, M | 1 |
| Ying, HM | 1 |
| Wang, XY | 1 |
| Sun, X | 1 |
| Shao, CH | 1 |
| Zhan, LX | 1 |
| Zhang, Y | 1 |
| Czamara, K | 1 |
| Karnas, E | 1 |
| Majka, Z | 1 |
| Wojcik, T | 1 |
| Zuba-Surma, EK | 1 |
| Baranska, M | 1 |
| Kaczor, A | 1 |
| Liu, X | 1 |
| Zhou, F | 1 |
| Yang, Y | 1 |
| Wang, W | 1 |
| Niu, L | 1 |
| Zuo, D | 1 |
| Li, X | 1 |
| Hua, H | 1 |
| Zhang, B | 1 |
| Kou, Y | 1 |
| Guo, J | 1 |
| Kong, F | 1 |
| Pan, W | 1 |
| Gao, D | 1 |
| Meves, JM | 1 |
| Sun, H | 1 |
| Xue, M | 1 |
| Zhang, Q | 1 |
| Wang, Y | 1 |
| Tang, R | 1 |
| Iso, T | 1 |
| Haruyama, H | 1 |
| Sunaga, H | 1 |
| Matsui, H | 1 |
| Matsui, M | 1 |
| Tanaka, R | 1 |
| Umbarawan, Y | 1 |
| Syamsunarno, MRAA | 1 |
| Putri, M | 1 |
| Yamaguchi, A | 1 |
| Hanaoka, H | 1 |
| Negishi, K | 1 |
| Yokoyama, T | 1 |
| Kurabayashi, M | 1 |
| Palomo-Briones, R | 1 |
| Esquivel-González, S | 1 |
| Aizpuru, A | 1 |
| Gómez-Hernández, N | 1 |
| Casas-Flores, S | 1 |
| Barba de la Rosa, AP | 1 |
| Arriaga, S | 1 |
| Peterson, ME | 1 |
| Carothers, MA | 1 |
| Gamble, DA | 1 |
| Rishniw, M | 1 |
| Yalcin, M | 2 |
| Lin, HY | 2 |
| Sudha, T | 2 |
| Bharali, DJ | 2 |
| Meng, R | 1 |
| Tang, HY | 1 |
| Davis, FB | 1 |
| Stain, SC | 1 |
| Davis, PJ | 2 |
| Mousa, SA | 2 |
| Darwish, NH | 1 |
| Debreli Coskun, M | 1 |
| Keating, KA | 1 |
| Murai, H | 1 |
| Murakami, S | 1 |
| Ishida, K | 1 |
| Sugawara, M | 1 |
| Eriksson, M | 1 |
| Ajmani, SK | 1 |
| Mallette, LE | 1 |
| Jones, BR | 1 |
| Gruffydd-Jones, TJ | 1 |
| Sparkes, AH | 1 |
| Lucke, VM | 1 |
| Rajatanavin, R | 1 |
| Liberman, C | 1 |
| Lawrence, GD | 1 |
| D'Arcangues, CM | 1 |
| Young, RA | 1 |
| Emerson, CH | 1 |
| Spitsa, AI | 1 |
| Arkhipenko, VI | 1 |
1 trial available for thyroxine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Bloo | 2018 |
9 other studies available for thyroxine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Topics: Humans; Hypothyroidism; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Thyroxine | 2022 |
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Topics: Humans; Hypothyroidism; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Thyroxine | 2022 |
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Topics: Humans; Hypothyroidism; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Thyroxine | 2022 |
Should patients on levothyroxine therapy be screened for pancreatic cancer?
Topics: Humans; Hypothyroidism; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Thyroxine | 2022 |
Thyroid hormones concentration in portal and peripheral blood in patients with pancreatic cancer: Preliminary study.
Topics: Aged; Biomarkers, Tumor; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; | 2020 |
Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Topics: Animals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic | 2013 |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug | 2017 |
Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro.
Topics: Aged; Cholecystectomy; Colorectal Neoplasms; Esophageal Neoplasms; Female; Humans; Interleukin-6; Ma | 1996 |
Hyperthyroidism from thyroid metastasis of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Humans; Hyperthyroidism; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasm | 1977 |
Preliminary studies on congenital hypothyroidism in a family of Abyssinian cats.
Topics: Animals; Breeding; Carcinoma, Intraductal, Noninfiltrating; Cat Diseases; Cats; Cholesterol; Congeni | 1992 |
Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma.
Topics: Adenoma, Islet Cell; Aged; Female; Humans; Male; Pancreatic Neoplasms; Prealbumin; Protein Binding; | 1985 |
[The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
Topics: Antibiotics, Antineoplastic; Carcinoma; Dactinomycin; Female; Flavonoids; In Vitro Techniques; Insul | 1971 |